Skip to content

Clinical metabonomics study of acupuncture and moxibustion in the treatment of menopausal women

Clinical metabonomics study of acupuncture and moxibustion in the treatment of menopausal women

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2100004705
Enrollment
Unknown
Registered
2021-04-07
Start date
2021-04-01
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Perimenopausal syndrome

Interventions

Sponsors

Shanghai Municipal Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
45 Years to 55 Years

Inclusion criteria

Inclusion criteria: 1.Women aged 45-55 years old who meet the diagnostic criteria; 2.In line with the international commonly used improved Kupperman scoring method, the score >= 15 points; 3.Patients who have not participated in other clinical trials; 4.Did not take any hormones or tranquilizers for 3 months before treatment; 5.Able to understand the provisions of the daily function scale and complete the assessment; 6.Agree to participate in the survey and sign a written informed consent.

Exclusion criteria

Exclusion criteria: 1.Primary hypertension, primary hypotension and chronic anemia; 2.Ovarian tumors, bilateral ovariectomy and premature ovarian failure. 3.Patients with serious primary diseases and mental illnesses such as the cardiovascular, cerebrovascular, liver, kidney and hematopoietic system.

Design outcomes

Primary

MeasureTime frame
Perimenopausal quality of life scale;

Secondary

MeasureTime frame
Frequency and degree of hot flashes;Self-rating Anxiety Scale;Self-rating Depression Scale;Menopause-specific Quality of Life;

Countries

China

Contacts

Public ContactXu Sshifen

Shanghai Municipal Hospital of Traditional Chinese Medicine

xu_teacher2006@126.com+86 13761931393

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026